Preliminary in vivo evaluation of [131I]-2-I-D-Phe as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumour bearing NuNu mice using bioluminescent imaging

MLA

Matthias Bauwens, et al. Preliminary in Vivo Evaluation of [131I]-2-I-D-Phe as a Potential Radionuclide Therapeutic Agent in R1M-Fluc Rhabdomyosarcoma Tumour Bearing NuNu Mice Using Bioluminescent Imaging. Apr. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..dc85be4379dc69701c28b64c5f5a0e14&authtype=sso&custid=ns315887.

APA

Matthias Bauwens, Lena Wimana, Marleen Keyaerts, Cindy Peleman, Tony Lahoutte, Ken Kersemans, Sarah Snykers, Mathieu Vinken, John Mertens, & Axel Bossuyt. (2010). Preliminary in vivo evaluation of [131I]-2-I-D-Phe as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumour bearing NuNu mice using bioluminescent imaging.

Chicago

Matthias Bauwens, Lena Wimana, Marleen Keyaerts, Cindy Peleman, Tony Lahoutte, Ken Kersemans, Sarah Snykers, Mathieu Vinken, John Mertens, and Axel Bossuyt. 2010. “Preliminary in Vivo Evaluation of [131I]-2-I-D-Phe as a Potential Radionuclide Therapeutic Agent in R1M-Fluc Rhabdomyosarcoma Tumour Bearing NuNu Mice Using Bioluminescent Imaging,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..dc85be4379dc69701c28b64c5f5a0e14&authtype=sso&custid=ns315887.